MindWalk Holdings (HYFT) Net Margin Growth (3y) (2023 - 2026)

MindWalk Holdings (HYFT) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -374.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -44.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -759,845.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 7,793.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 82,312.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -5,319.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 9,934.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 31,387.00
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -1.86 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 79,214.00
Oct 31, 2025 -10,081.00
Jul 31, 2025 3.57 Mn
Apr 30, 2025 37,240.00
Jan 31, 2025 2,020.00
Oct 31, 2024 15,149.00
Jul 31, 2024 7,740.00
Apr 30, 2024 9.28 Bn
Jan 31, 2024 6,810.00
Oct 31, 2023 2.88 Mn
Jul 31, 2023 7.34 Mn